Liminal's stock price As I said last week, the market has not given any kind of importance to the approval of Ryplazim. I expected this stock to trend toward near zero value over time. I see that the evolution of its price since the famous approval is moving inexorably towards that. To be more precise, and unless something spectacularly positive happens in the next few weeks/months, I predict that by the end of the month (week?), Liminal's stock should be around $3.50, around $2 at the end of July, and certainly under $1 in August. And a few cents in September. As for Piper's $4.50 forecast, I find it laughable and more importantly, without any kind of support from concrete facts or serious expectations.